Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Abstract

Our data show that both low natalizumab serum concentration and high antibody titers are associated with a lack of efficacy of natalizumab. Measuring serum natalizumab, using a highly specific assay, might lead to more enhanced precision using natalizumab in individual patients.